Scott Plotkin
Overview
Explore the profile of Scott Plotkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
1086
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dhaenens B, Heimann G, Bakker A, Nievo M, Ferner R, Evans D, et al.
Neurooncol Pract
. 2024 Jul;
11(4):395-403.
PMID: 39006526
Background: Neurofibromatosis type 1, -related schwannomatosis and non--related schwannomatosis (grouped under the abbreviation "NF") are rare hereditary tumor predisposition syndromes. Due to the low prevalence, variability in the range, and...
2.
Richey P, Funk M, Sakamoto F, Plotkin S, Ly I, Jordan J, et al.
J Am Acad Dermatol
. 2023 Dec;
90(4):767-774.
PMID: 38086517
Background: People with Neurofibromatosis Type 1 (NF1) suffer disfigurement and pain when hundreds to thousands of cutaneous neurofibromas (cNFs) appear and grow throughout life. Surgical removal of cNFs under anesthesia...
3.
Zhang J, Chen W, Ly K, Zhang X, Yan F, Jordan J, et al.
IEEE J Biomed Health Inform
. 2021 Jun;
26(2):786-797.
PMID: 34106871
Neurofibromatosis type 1 (NF1) is an autosomal dominant tumor predisposition syndrome that involves the central and peripheral nervous systems. Accurate detection and segmentation of neurofibromas are essential for assessing tumor...
4.
Lester E, Macklin E, Plotkin S, Vranceanu A
J Neurooncol
. 2020 Feb;
147(2):451-457.
PMID: 32078086
Purpose: To examine effects of a virtual mind-body group for adolescents with neurofibromatoses (NF1 and NF2; Resilient Youth with Neurofibromatosis; RY-NF) on multiple resiliency factors against a health education attention...
5.
Lester E, DiStefano S, Mace R, Macklin E, Plotkin S, Vranceanu A
Gen Hosp Psychiatry
. 2019 Dec;
62:72-78.
PMID: 31841875
Objective: To examine the feasibility, acceptability, preliminary effect, and durability of a mind-body videoconferencing program for youth with neurofibromatosis (Resilient Youth with NF; RY-NF) against an experimental educational control (Health...
6.
Greenberg J, Carter S, Lester E, Funes C, Macklin E, Plotkin S, et al.
J Neurooncol
. 2019 Nov;
145(3):561-569.
PMID: 31677033
Introduction: Patients with NF2 who are deaf or have significant hearing loss face numerous and unique challenges which lead to poor quality of life, and thus may benefit from resiliency...
7.
Ferner R, Bakker A, Elgersma Y, Evans D, Giovannini M, Legius E, et al.
Am J Med Genet A
. 2019 Mar;
179(6):1098-1106.
PMID: 30908866
The neurofibromatoses are inherited, tumor suppressor disorders that are characterized by multiple, benign peripheral nerve sheath tumors and other nervous system tumors. Each disease is associated with a distinct genetic...
8.
Brastianos P, Nayyar N, Rosebrock D, Leshchiner I, Gill C, Livitz D, et al.
NPJ Precis Oncol
. 2018 Jun;
1(1):33.
PMID: 29872714
Glioblastomas are malignant neoplasms composed of diverse cell populations. This intratumoral diversity has an underlying architecture, with a hierarchical relationship through clonal evolution from a common ancestor. Therapies are limited...
9.
Korf B, Ahmadian R, Allanson J, Aoki Y, Bakker A, Burkitt Wright E, et al.
Am J Med Genet A
. 2015 Apr;
167A(8):1741-6.
PMID: 25900621
"The Third International Meeting on Genetic Disorders in the RAS/MAPK Pathway: Towards a Therapeutic Approach" was held at the Renaissance Orlando at SeaWorld Hotel (August 2-4, 2013). Seventy-one physicians and...
10.
Fayad L, Blakeley J, Plotkin S, Widemann B, Jacobs M
ISRN Radiol
. 2014 Jun;
2013:627932.
PMID: 24967287
Purpose. WB-MRI is mainly used for tumor detection and surveillance. The purpose of this study is to establish the feasibility of WB-MRI at 3T for lesion characterization, with DWI/ADC-mapping and...